跳至主要内容
临床试验/NCT04137744
NCT04137744已完成不适用

Evaluation of Axillary Reverse Mapping (ARM) in Clinically Axillary Node Negative Breast Cancer Patients

Zagazig University2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
2
主要终点
histopathologic examination of ARM +ve LN

研究概览

简要总结

study patients; axillary node negative breast cancer female, 74 patients randomly allocated in two groups each 37 patients , group I , where axillary reverse mapping(ARM) +ve nodes were preserved and axillary lymph node dissection completed.and group II where axillary reverse mapping +ve nodes were taken with axillary lymph node dissection(ALND) primary outcome is histopathological examination of a ARM +ve lymph nodes and volume measurements of the ipsilateral arm for development of lymphedema at 6 ,12 , and 24 months

详细描述

This study is comparative clinical trial carried out in the period between February 2015 and August 2019 on 74 female patients with early breast cancer. All patients were informed and signed a written consent. The study was approved from institutional review board (IRB) and ethical committee of our university.

Patient selection Patients included in the study are female patients above 18 years old, known breast cancer with clinically negative nodal metastasis who were admitted for completion ALND, after positive sentinel lymph node biopsy (SLNB).

Patients excluded from the study are those who had received chemotherapy for breast cancer, recurrent cases after conservative breast surgery, bilateral disease and pregnant cases.

Patients were randomly divided into two equal groups each 37 patients, group A; (ARM preserving ALND), where arm lymphatics and lymph nodes were identified and preserved, subsequently ALND was completed, group B; where arm lymphatics and lymph nodes were identified, marked and removed with ALND.

Technical procedures:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • clinically free breast cancer
  • sentinle LN positive

排除标准

  • patients on chemotherapy for breast cancer
  • recurrent cases after conservative breast surgery
  • bilateral disease and pregnant cases

结局指标

主要结局

histopathologic examination of ARM +ve LN

时间窗: IMMEDIATE POSTOPERATIVE

EITHER +VE OR -VE

ARM LYMPHOEDEMA

时间窗: 2 years postoperative

INCREASE OF THE ARM VOLUME BY 10%

次要结局

  • restriction of shoulder movement(2 years)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hazem Nour Abdellatif

Assistant professor

Zagazig University

研究点 (2)

Loading locations...

相似试验